bioRxiv to Help Scientists Share Research Faster

The Chan Zuckerberg Initiative is partnering with Cold Spring Harbor Laboratory to support and build out bioRxiv to help scientists share research faster. bioRxiv is quickly becoming the standard database for pre-publishing biological research, and CZI is proud to support their work and help build out their service to accelerate science.

Mark Zuckerberg:
I’m excited the Chan Zuckerberg Initiative is partnering with Cold Spring Harbor Laboratory to support and build out bioRxiv to help scientists share research faster.

If we’re going to cure all disease in our children’s lifetime, we need to speed up science. One thing that slows us down today is that it can take a year or longer to publish research in a scientific journal. It’s common for scientists to be working on a problem for a long time and then when another paper finally publishes, they realize someone solved their problem or found a better approach a long time ago. It can be a huge waste of time, and if we can help eliminate it, scientific progress can move a lot faster.

That’s what bioRxiv does. bioRxiv is a free service that lets scientists share drafts or their results, or “preprints”, before they’re published. It’s quickly becoming the standard database for pre-publishing biological research. We’re proud to support their work and help build out their service to accelerate science.

News

  • GEN: Virtual Cells Go Multiscale to Predict Complex Biology

    AI models inform therapeutics that can restore diseased cells to healthy states

  • Protein Modeling, Cell Imaging and Patient-Powered Science: Reflections on Biohub’s Start to the Year

    Co-founder Priscilla Chan shares reflections following Aspen Ideas: Health on the models, tools, and people driving Biohub's progress this year.

  • Surprising drug targets for psoriasis emerge from comprehensive CRISPR study of human skin cells

    Analysis of results by AI ‘novelty filter’ led researchers to formulate topical gels that, in mice, were as effective as widely used injected therapy.